共 50 条
- [1] Ruxolitinib for Myelofibrosis: From 'Palliation' to Prolongation of Survival THE KREMYANSKAYA ET A ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (07): : 717 - 718
- [2] Natural history and treatment of malignant thymoma - The Cowen et al article reviewed ONCOLOGY-NEW YORK, 1998, 12 (07): : 1006 - 1006
- [3] Discussing disease progression and end-of-life decisions - The Baile et al article reviewed ONCOLOGY-NEW YORK, 1999, 13 (07): : 1031 - 1032
- [5] Prostate-specific antigen as a marker of disease activity in prostate cancer - The Partin et al article reviewed ONCOLOGY-NEW YORK, 2002, 16 (09): : 1228 - +
- [6] Prostate-specific antigen as a marker of disease activity in prostate cancer - The Partin et al article reviewed ONCOLOGY-NEW YORK, 2002, 16 (08): : 1042 - +
- [7] Transplant registries: Guiding clinical decisions and improving outcomes - The Horowitz et al article reviewed ONCOLOGY-NEW YORK, 2001, 15 (05): : 666 - 666
- [8] Improving palliative and supportive care in cancer patients - The Khatcheressian/Cassel/Lyckholm et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (10): : 1384 - +